The highest dosage of the drug resulted in an average of 10.5% reduction in weight (22.9 pounds) compared to the 2.2% reduction in weight in the placebo
Existing skin conditions : Avoid areas with eczema, psoriasis, scarring, or other skin changes
A groundbreaking study from National Yang Ming Chiao Tung University (NYCU) and Taipei Veterans General Hospital (TVGH) has uncovered an unexpected culprit behind sarcopeniaa condition traditionally associated with aging and physical decline
Without support in areas like nutrition and physical activity, you may miss out on the full benefits of GLP-1 therapy and are more likely to experience weight regain once the medication is discontinued
Elderly patients with cardiac conditions or those taking loop or thiazide diuretics may be particularly vulnerable
Furthermore, diverse patient populations, encompassing individuals with various psychiatric and medical comorbidities, introduce complexities in the extrapolation of results